Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193474 | SCV000247184 | uncertain significance | not specified | 2015-02-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001034651 | SCV000546537 | uncertain significance | Familial focal epilepsy with variable foci | 2024-01-28 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 1104 of the DEPDC5 protein (p.Ser1104Leu). This variant is present in population databases (rs79027628, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of DEPDC5-related conditions (PMID: 23542697, 29356177, 31139143, 31594065). ClinVar contains an entry for this variant (Variation ID: 210846). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002317677 | SCV000851156 | likely benign | Inborn genetic diseases | 2019-06-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000254574 | SCV000895416 | uncertain significance | Epilepsy, familial focal, with variable foci 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000254574 | SCV001141410 | uncertain significance | Epilepsy, familial focal, with variable foci 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000254574 | SCV001525504 | uncertain significance | Epilepsy, familial focal, with variable foci 1 | 2019-04-19 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. This c.3311C>T (p.S1104L) variant has been previously reported in patients with FFEVF1 or paroxysmal kinesigenic dyskinesia [PMID 23542697, 29356177], however, another study found this variant lacks strong segregation support [PMID 28717674] |
Gene |
RCV001668361 | SCV001889294 | benign | not provided | 2020-06-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31639411, 31594065, 31139143, 30093711, 28717674, 23542697, 29356177, 25366275, 27683934) |
Revvity Omics, |
RCV001668361 | SCV003834327 | uncertain significance | not provided | 2022-04-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000254574 | SCV000321059 | not provided | Epilepsy, familial focal, with variable foci 1 | no assertion provided | literature only | ||
Service de Génétique Moléculaire, |
RCV000254574 | SCV001432416 | likely benign | Epilepsy, familial focal, with variable foci 1 | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004751356 | SCV005359242 | likely benign | DEPDC5-related disorder | 2024-07-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |